Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Ready. Raise. Rise. For CRI

    Raise a flag in honor of someone affected by cancer and help us win a $75,000 donation.

    July 13, 2015| Emily Helck
  • New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer

    Patients with lung cancer will soon be able to receive immunotherapy as first-line treatment on an experimental…

    July 7, 2015| Matthew Tontonoz
  • When Is a Spot Not a Spot?

    A ten-year effort to optimize a ubiquitous laboratory assay finally pays off.

    July 2, 2015| Matthew Tontonoz
  • Giving 100% to ‘100 in 100’ – YOU DID IT!

    A big thank you to all of our supporters who made $100K in 100 Days a success!

    July 1, 2015| Hannah Belisle
  • Immunotherapy: 5 Ways to Stop Cancer

    The Cancer Research Institute has created a series of short, animated videos that explain the basics of…

    June 26, 2015| Matthew Tontonoz
  • White Out Cancer 2015

    More than 1,000 posts from around the globe were shared in the third annual event.

    June 17, 2015| Emily Helck
  • CRI Member to Chair Immuno-Oncology 360 Conference

    Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…

    June 17, 2015| Alexandra Mulvey
  • What Cancer Patients Should Know: Latest Immunotherapy News from ASCO

    Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer…

    June 5, 2015| CRI Staff
  • ASCO 2015: Report from Day 5

    The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…

    June 2, 2015| Matthew Tontonoz
Previous Page
1 … 85 86 87 88 89 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization, and our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal